V-Wave

Recent Finacing

Series C ext

Recent Raise

$98M

V-Wave develops and implants a minimally invasive transvenous interatrial shunt that regulates left atrial pressure to relieve pulmonary congestion in chronic symptomatic heart failure, evaluated in randomized clinical trials.

Founded 2010

Hefa, Israel

51-100

Private

vwavemedical.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Medical Device

Recent Investors

G

Financials

$196M

Total Raised

3

Funding rounds

13

Investors

Team

Upgrade to view the team

See the team members at V-Wave.